Alzheimer’s disease linked to the metabolism of unsaturated fats, new research finds
A new study published in PLOS Medicine's Special Issue on Dementia has found that the metabolism of omega-3 and omega-6 unsaturated fatty acids in the brain are associated with the progression of Alzheimer's disease.
Alzheimer's disease is a neurodegenerative disorder, which causes impaired memory, executive function and language. It accounts for 60 – 80% of total dementia cases worldwide, with over 46 million people suffering from the disease worldwide. The number of patients is estimated to rise to 131.5 million by 2050.
Currently it is thought that the main reason for developing memory problems in dementia is the presence of two big molecules in the brain called tau and amyloid proteins. These proteins have been extensively studied and have been shown to start accumulating in the brain up to 20 years prior to the onset of the disease. However, there is limited information on how small molecule metabolism in the brain is associated with the development and progression of Alzheimer's disease.
In this study, researchers from King's College London and the National Institute on Aging in the United States looked at brain tissue samples from 43 people ranging in age from 57 to 95 years old. They compared the differences in hundreds of small molecules in three groups: 14 people with healthy brains, 15 that had high levels of tau and amyloid but didn't show memory problems and 14 clinically diagnosed Alzheimer's patients.
They also looked at three different areas in the brain, one that usually shows little tau and amyloid, one that shows more tau and another that shows more amyloid. The main molecules that were different were six small fats, including omegas, which changed in abundance in different regions of the brain.
They found that unsaturated fatty acids were significantly decreased in Alzheimer's brains when compared to brains from healthy patients.
Co-lead author of the study, Dr Cristina Legido Quigley from King's College London said: "While this was a small study, our results show a potentially crucial and unexpected role for fats in the onset of dementia. Most surprisingly we found that a supposedly beneficial omega3, DHA, actually increased with the progression of the disease.
"It is now important for us to build on and replicate these findings in a larger study and see whether it corroborates our initial findings."
This study was made possible thanks to the generous donation of volunteers from the Baltimore Longitudinal Study of Aging.
For further information please contact the Public Relations Department at King's College London on 0207 848 3202 or [email protected]
'Unsaturated fatty acid metabolism in Alzheimer's disease' by Snowden et al is published online in PLOS Medicine on Tuesday 21 March 2017.
About King's College London
King's College London is one of the top 25 universities in the world (2016/17 QS World University Rankings) and among the oldest in England. King's has more than 27,600 students (of whom nearly 10,500 are graduate students) from some 150 countries worldwide, and some 6,800 staff.
King's has an outstanding reputation for world-class teaching and cutting-edge research. In the 2014 Research Excellence Framework (REF) King's was ranked 6th nationally in the 'power' ranking, which takes into account both the quality and quantity of research activity, and 7th for quality according to Times Higher Education rankings. Eighty-four per cent of research at King's was deemed 'world-leading' or 'internationally excellent' (3* and 4*). The university is in the top seven UK universities for research earnings and has an overall annual income of more than £684 million.
For further information, please visit the website: http://www.kcl.ac.uk/newsevents/About-Kings.aspx